Table 1.
Participant socio‐demographics and clinical setting
| Number | Age, Gender | Diagnosis | Stages | Radiation | Chemotherapy |
|---|---|---|---|---|---|
| 1 | 75m | non‐small | IV | yes | Second‐line therapy, 9 cycles; intravenous |
| 2 | 68m | Small | IV | no | Second‐line therapy, 2 cycles; intravenous |
| 3 | 61f | non‐small | IV | yes | Third‐line therapy, oral |
| 4 | 63m | non‐small | IV | yes | Second‐line therapy, 2 cycles, intravenous |
| 5 | 48f | non‐small | IV | yes | First‐line therapy, oral |
| 6 | 74m | non‐small | IV | no | First‐line therapy, oral |
| 7 | 59f | non‐small | IV | yes | First‐line therapy, 10 cycles; intravenous |
| 8 | 70f | non‐small | IV | yes | First‐line therapy, oral |
| 9 | 69m | non‐small | IV | no | Fourth‐line therapy, 2 cycles; intravenous |
| 10 | 65m | Small | IV | no | First‐line therapy, 1 cycle; intravenous |
| 11 | 76f | non‐small | IIIA | no | First‐line therapy, 2 cycles; intravenous |
| 12 | 65m | non‐small | IV | yes | Second‐line therapy, 2 cycles; intravenous |
| 13 | 60m | non‐small | IIIB | yes | Third‐line therapy, 2 cycles; intravenous |
| 14 | 72m | non‐small | IV | yes | Third‐line therapy, 7 cycles; intravenous |
| 15 | 61f | non‐small | IV | yes | Fifth‐line therapy, oral |
| 16 | 70m | non‐small | IV | yes | Second‐line therapy, 97 cycles; intravenous, maintenance therapy |
| 17 | 75m | small | IIIB | yes | Second‐line therapy, 2 cycles; intravenous |
| 18 | 67f | non‐small | IV | no | Second‐line therapy, oral |
f = female, m = male.